Halozyme Therapeutics shares owned by Thrivent Financial for Lutherans
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Thrivent Financial for Lutherans
from 13F filings
Historical chart of Thrivent Financial for Lutherans investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Thrivent Financial for Lutherans consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Thrivent Financial for Lutherans
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $13M | 233k | 57.23 |
2024-03-31 | $70M | 1.7M | 40.68 |
2023-09-30 | $77M | 2.0M | 38.20 |
2023-06-30 | $75M | 2.1M | 36.07 |
2023-03-31 | $41M | 1.1M | 38.19 |
2022-12-31 | $52M | 920k | 56.90 |
2022-09-30 | $52M | 1.3M | 39.54 |
2022-06-30 | $58M | 1.3M | 44.00 |
2022-03-31 | $59M | 1.5M | 39.88 |
2021-12-31 | $43M | 1.1M | 40.21 |
2021-09-30 | $31M | 753k | 40.68 |
2021-06-30 | $35M | 768k | 45.41 |
2021-03-31 | $31M | 734k | 41.69 |
2020-12-31 | $53M | 1.2M | 42.71 |
2020-09-30 | $31M | 1.2M | 26.28 |
2020-06-30 | $32M | 1.2M | 26.81 |
2020-03-31 | $21M | 1.2M | 17.99 |
2019-12-31 | $21M | 1.2M | 17.73 |
2019-09-30 | $60M | 3.9M | 15.51 |
2019-06-30 | $65M | 3.8M | 17.18 |
2019-03-31 | $59M | 3.7M | 16.10 |
2018-12-31 | $52M | 3.6M | 14.63 |
2018-09-30 | $57M | 3.1M | 18.17 |
2018-06-30 | $39M | 2.3M | 16.87 |
More positions owned by Thrivent Financial for Lutherans
View all positions for Thrivent Financial for Lutherans